Strata Oncology Strata Oncology Trial Data Support Robustness of NGS Assay for Challenging Samples Premium The company said the results highlight precision oncology implementation challenges and its test's ability to help overcome these issues. Strata Oncology Raises $90M in Series C Financing The firm said it will use the proceeds to accelerate development of its MRD assay for early-stage cancers and its treatment selection tests for solid tumors. People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Strata Oncology, Pfizer Partner to Explore New Biomarker Indications for FDA-Approved Drugs Pfizer is the first drugmaker to join the Strata PATH platform trial and will contribute drugs to advanced cancer patients in four study arms. Strata Oncology Receives Medicare Coverage for NGS Test The test assesses multiple factors, including single-/multi-nucleotide variants, short insertions and deletions, and microsatellite instability status. Aug 13, 2020 Strata, Mirati Therapeutics Partner on Tumor-Agnostic Clinical Trial of Novel KRAS G12C Inhibitor Jul 29, 2020 Strata Oncology, BioMed Valley Discoveries Partner on Patient Enrollment for Ulixertinib Study May 2, 2019 Arcus Biosciences, Strata Oncology Team Up to Advance Anti-PD-1 Drug Sep 5, 2018 Strata Oncology to Help Identify Patients for NCI-MATCH Precision Medicine Study Jul 17, 2018 Strata Oncology to Aid Puma Biotech in Recruiting for Neratinib HER2 Basket Study May 23, 2018 Strata Oncology Raises $26M in Series B Financing Round Apr 5, 2018 Strata Oncology Aims to Streamline Molecular Testing, Clinical Trial Enrollment for Cancer Patients Premium Dec 15, 2017 In Brief This Week: Abbott, Strata Oncology, Premaitha, Science Exchange, Clearbridge BioMedics, More Oct 3, 2017 Strata Oncology, UCSF Launch Prostate Cancer Precision Medicine Initiative Feb 6, 2017 Strata Oncology, Epizyme Partner to Pick Cancer Patients for Drug Trial Feb 1, 2017 Clovis, Strata Partner to Identify Prostate Cancer Best Responders to PARP Inhibitor Dec 16, 2016 Strata Oncology Launches Study to Match Cancer Patients With Clinical Trials Breaking News CDC Awards $22M to Combat Antimicrobial Resistance, Infectious Diseases Pan-Cancer Analysis Reveals Unique Features in Tumors From Younger People Breast Cancer Therapy Response Predicted by Multiomic Machine Learning Model Cytena Inks China Distribution Deal for Single-Cell Isolators Freenome Raises $300M in Series D Financing More Than Dozen Genetic Loci Linked to Amyotrophic Lateral Sclerosis Risk The Scan Less Than Half An effort to reproduce key findings from high-profile preclinical cancer studies finds less than half could be replicated, according to the Scientist. Still Some SARS-CoV-2 Sequencing Holes The Wall Street Journal reports that viral genomic surveillance has improved in the US, though says there are still gaps. Avoiding Passing Them On People with known disease-linked genetic variants are turning to in vitro fertilization so as to not pass those variants to their children, the Washington Post says. PNAS Papers on Long Cell-Free DNA in Maternal Plasma, Genetic Propensity for Voting In PNAS this week: long, cell-free DNA of maternal and fetal origins identified in maternal plasma, and more.